131 related articles for article (PubMed ID: 23709189)
1. Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.
Goldberg AA; Titorenko VI; Beach A; Abdelbaqi K; Safe S; Sanderson JT
Invest New Drugs; 2014 Feb; 32(1):25-36. PubMed ID: 23709189
[TBL] [Abstract][Full Text] [Related]
2. Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK).
Draz H; Goldberg AA; Titorenko VI; Tomlinson Guns ES; Safe SH; Sanderson JT
Cell Signal; 2017 Dec; 40():172-182. PubMed ID: 28923415
[TBL] [Abstract][Full Text] [Related]
3. 3,3'-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and -independent prostate cancer cells.
Goldberg AA; Draz H; Montes-Grajales D; Olivero-Verbél J; Safe SH; Sanderson JT
Genes Cancer; 2015 May; 6(5-6):265-280. PubMed ID: 26124925
[TBL] [Abstract][Full Text] [Related]
4. Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model.
Draz H; Goldberg AA; Tomlinson Guns ES; Fazli L; Safe S; Sanderson JT
Invest New Drugs; 2018 Aug; 36(4):718-725. PubMed ID: 29607466
[TBL] [Abstract][Full Text] [Related]
5. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.
Chinnakannu K; Chen D; Li Y; Wang Z; Dou QP; Reddy GP; Sarkar FH
J Cell Physiol; 2009 Apr; 219(1):94-9. PubMed ID: 19062173
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
[TBL] [Abstract][Full Text] [Related]
8. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
[TBL] [Abstract][Full Text] [Related]
9. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.
Ringer L; Sirajuddin P; Yenugonda VM; Ghosh A; Divito K; Trabosh V; Patel Y; Brophy A; Grindrod S; Lisanti MP; Rosenthal D; Brown ML; Avantaggiati ML; Rodriguez O; Albanese C
Cancer Biol Ther; 2010 Aug; 10(4):320-5. PubMed ID: 20574155
[TBL] [Abstract][Full Text] [Related]
10. Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells.
Xu Y; Zheng J; Ye ZY
Neoplasma; 2022 Sep; 69(5):1119-1128. PubMed ID: 36004650
[TBL] [Abstract][Full Text] [Related]
11. L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1/MEK/ERK/STAT3/PAX2 apoptotic pathways.
Zhang D; Liu H; Yang B; Hu J; Cheng Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975734
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
[TBL] [Abstract][Full Text] [Related]
13. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin induces apoptosis in human prostate cancer cells through both intrinsic and extrinsic pathways.
Yang PY; Hu DN; Kao YH; Lin IC; Chou CY; Wu YC
Pharmacol Rep; 2016 Oct; 68(5):874-80. PubMed ID: 27351942
[TBL] [Abstract][Full Text] [Related]
15. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
[TBL] [Abstract][Full Text] [Related]
16. Effects of a novel carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleoside on pleiotropic induction of cell death in prostate cancer cells with different androgen responsiveness.
Suh H; Choi KW; Lee J; Ryou C; Rhee H; Lee CH
Bioorg Med Chem Lett; 2016 Feb; 26(4):1130-5. PubMed ID: 26832220
[TBL] [Abstract][Full Text] [Related]
17. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
Forbes A; Anoopkumar-Dukie S; Chess-Williams R; McDermott C
Prostate; 2016 Jun; 76(8):757-66. PubMed ID: 26880388
[TBL] [Abstract][Full Text] [Related]
18. Kaempferol Promotes Apoptosis While Inhibiting Cell Proliferation via Androgen-Dependent Pathway and Suppressing Vasculogenic Mimicry and Invasion in Prostate Cancer.
Da J; Xu M; Wang Y; Li W; Lu M; Wang Z
Anal Cell Pathol (Amst); 2019; 2019():1907698. PubMed ID: 31871879
[TBL] [Abstract][Full Text] [Related]
19. Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells.
Colombero C; Papademetrio D; Sacca P; Mormandi E; Alvarez E; Nowicki S
Horm Cancer; 2017 Aug; 8(4):243-256. PubMed ID: 28639228
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells.
Fajardo AM; MacKenzie DA; Olguin SL; Scariano JK; Rabinowitz I; Thompson TA
PLoS One; 2016; 11(3):e0151525. PubMed ID: 26986969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
